vs

Side-by-side financial comparison of NU SKIN ENTERPRISES, INC. (NUS) and STONERIDGE INC (SRI). Click either name above to swap in a different company.

NU SKIN ENTERPRISES, INC. is the larger business by last-quarter revenue ($370.3M vs $205.2M, roughly 1.8× STONERIDGE INC). On growth, STONERIDGE INC posted the faster year-over-year revenue change (-6.0% vs -16.9%). NU SKIN ENTERPRISES, INC. produced more free cash flow last quarter ($5.9M vs $2.6M). Over the past eight quarters, NU SKIN ENTERPRISES, INC.'s revenue compounded faster (-5.8% CAGR vs -7.4%).

Nu Skin Enterprises, Inc. is an American multilevel marketing company that develops and sells personal care products and dietary and nutritional supplements. Under the Nu Skin and Pharmanex brands, the company sells its products in 54 markets through a network of approximately 1.2 million independent distributors.

Stoneridge Inc is a global designer and manufacturer of advanced electrical and electronic components, integrated systems, and sensor solutions. It serves automotive, commercial vehicle, off-highway, and aerospace sectors, delivering products that boost vehicle safety, efficiency, connectivity, and environmental performance across key global markets.

NUS vs SRI — Head-to-Head

Bigger by revenue
NUS
NUS
1.8× larger
NUS
$370.3M
$205.2M
SRI
Growing faster (revenue YoY)
SRI
SRI
+10.9% gap
SRI
-6.0%
-16.9%
NUS
More free cash flow
NUS
NUS
$3.2M more FCF
NUS
$5.9M
$2.6M
SRI
Faster 2-yr revenue CAGR
NUS
NUS
Annualised
NUS
-5.8%
-7.4%
SRI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NUS
NUS
SRI
SRI
Revenue
$370.3M
$205.2M
Net Profit
$14.5M
Gross Margin
70.7%
16.2%
Operating Margin
6.3%
-14.4%
Net Margin
3.9%
Revenue YoY
-16.9%
-6.0%
Net Profit YoY
140.1%
EPS (diluted)
$0.27
$-2.76

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NUS
NUS
SRI
SRI
Q4 25
$370.3M
$205.2M
Q3 25
$364.2M
$210.3M
Q2 25
$386.1M
$228.0M
Q1 25
$364.5M
$217.9M
Q4 24
$445.6M
$218.2M
Q3 24
$430.1M
$213.8M
Q2 24
$439.1M
$237.1M
Q1 24
$417.3M
$239.2M
Net Profit
NUS
NUS
SRI
SRI
Q4 25
$14.5M
Q3 25
$17.1M
$-9.4M
Q2 25
$21.1M
$-9.4M
Q1 25
$107.5M
$-7.2M
Q4 24
$-36.1M
Q3 24
$8.3M
$-7.1M
Q2 24
$-118.3M
$2.8M
Q1 24
$-533.0K
$-6.1M
Gross Margin
NUS
NUS
SRI
SRI
Q4 25
70.7%
16.2%
Q3 25
70.5%
20.3%
Q2 25
68.8%
21.5%
Q1 25
67.8%
21.2%
Q4 24
62.7%
19.5%
Q3 24
70.1%
20.8%
Q2 24
70.0%
22.7%
Q1 24
70.5%
20.2%
Operating Margin
NUS
NUS
SRI
SRI
Q4 25
6.3%
-14.4%
Q3 25
5.9%
-1.6%
Q2 25
8.0%
-1.1%
Q1 25
-2.7%
-1.5%
Q4 24
-11.9%
-2.0%
Q3 24
4.2%
0.1%
Q2 24
-28.6%
1.4%
Q1 24
2.1%
0.1%
Net Margin
NUS
NUS
SRI
SRI
Q4 25
3.9%
Q3 25
4.7%
-4.5%
Q2 25
5.5%
-4.1%
Q1 25
29.5%
-3.3%
Q4 24
-8.1%
Q3 24
1.9%
-3.3%
Q2 24
-26.9%
1.2%
Q1 24
-0.1%
-2.6%
EPS (diluted)
NUS
NUS
SRI
SRI
Q4 25
$0.27
$-2.76
Q3 25
$0.34
$-0.34
Q2 25
$0.43
$-0.34
Q1 25
$2.14
$-0.26
Q4 24
$-0.73
$-0.22
Q3 24
$0.17
$-0.26
Q2 24
$-2.38
$0.10
Q1 24
$-0.01
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NUS
NUS
SRI
SRI
Cash + ST InvestmentsLiquidity on hand
$239.8M
$66.3M
Total DebtLower is stronger
$180.9M
Stockholders' EquityBook value
$805.2M
$179.8M
Total Assets
$1.4B
$551.2M
Debt / EquityLower = less leverage
1.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NUS
NUS
SRI
SRI
Q4 25
$239.8M
$66.3M
Q3 25
$253.0M
$54.0M
Q2 25
$265.4M
$49.8M
Q1 25
$213.6M
$79.1M
Q4 24
$198.0M
$71.8M
Q3 24
$237.8M
$54.1M
Q2 24
$232.9M
$42.1M
Q1 24
$221.2M
$48.4M
Total Debt
NUS
NUS
SRI
SRI
Q4 25
$180.9M
Q3 25
Q2 25
Q1 25
Q4 24
$201.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
NUS
NUS
SRI
SRI
Q4 25
$805.2M
$179.8M
Q3 25
$799.8M
$251.2M
Q2 25
$787.8M
$260.5M
Q1 25
$754.0M
$253.1M
Q4 24
$651.5M
$245.3M
Q3 24
$706.9M
$271.4M
Q2 24
$686.2M
$270.5M
Q1 24
$810.2M
$277.3M
Total Assets
NUS
NUS
SRI
SRI
Q4 25
$1.4B
$551.2M
Q3 25
$1.4B
$632.1M
Q2 25
$1.4B
$639.4M
Q1 25
$1.4B
$657.4M
Q4 24
$1.5B
$621.6M
Q3 24
$1.6B
$662.5M
Q2 24
$1.6B
$666.7M
Q1 24
$1.7B
$675.4M
Debt / Equity
NUS
NUS
SRI
SRI
Q4 25
1.01×
Q3 25
Q2 25
Q1 25
Q4 24
0.82×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NUS
NUS
SRI
SRI
Operating Cash FlowLast quarter
$16.6M
$8.8M
Free Cash FlowOCF − Capex
$5.9M
$2.6M
FCF MarginFCF / Revenue
1.6%
1.3%
Capex IntensityCapex / Revenue
2.9%
3.0%
Cash ConversionOCF / Net Profit
1.15×
TTM Free Cash FlowTrailing 4 quarters
$46.0M
$12.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NUS
NUS
SRI
SRI
Q4 25
$16.6M
$8.8M
Q3 25
$27.5M
$3.6M
Q2 25
$35.8M
$10.7M
Q1 25
$389.0K
$10.9M
Q4 24
$25.8M
$19.2M
Q3 24
$31.4M
$10.8M
Q2 24
$51.2M
$8.7M
Q1 24
$3.3M
$9.1M
Free Cash Flow
NUS
NUS
SRI
SRI
Q4 25
$5.9M
$2.6M
Q3 25
$17.6M
$-2.7M
Q2 25
$35.8M
$7.4M
Q1 25
$-13.2M
$4.8M
Q4 24
$13.2M
$14.0M
Q3 24
$22.8M
$4.6M
Q2 24
$43.1M
$1.5M
Q1 24
$-9.0M
$3.3M
FCF Margin
NUS
NUS
SRI
SRI
Q4 25
1.6%
1.3%
Q3 25
4.8%
-1.3%
Q2 25
9.3%
3.3%
Q1 25
-3.6%
2.2%
Q4 24
3.0%
6.4%
Q3 24
5.3%
2.2%
Q2 24
9.8%
0.6%
Q1 24
-2.1%
1.4%
Capex Intensity
NUS
NUS
SRI
SRI
Q4 25
2.9%
3.0%
Q3 25
2.7%
3.0%
Q2 25
0.0%
1.4%
Q1 25
3.7%
2.8%
Q4 24
2.8%
2.4%
Q3 24
2.0%
2.9%
Q2 24
1.9%
3.0%
Q1 24
2.9%
2.4%
Cash Conversion
NUS
NUS
SRI
SRI
Q4 25
1.15×
Q3 25
1.61×
Q2 25
1.69×
Q1 25
0.00×
Q4 24
Q3 24
3.79×
Q2 24
3.11×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NUS
NUS

Other$161.9M44%
Mainland China Segment$52.0M14%
Southeast Asia Pacific Segment$50.5M14%
Europe And Africa Segment$41.8M11%
Hong Kong Taiwan Segment$29.6M8%
South Korea Segment$28.4M8%
Rhyz Other Segment$6.1M2%

SRI
SRI

Control Devices$51.7M25%
Electronics$38.0M19%
EE$34.2M17%
SE$28.6M14%
NL$24.5M12%
Stoneridge Brazil$14.1M7%
Asia Pacific$13.1M6%

Related Comparisons